Monday, June 22, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 519 of 1,261

  1. US 10195279

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Feb 5, 2019 · Expires Jan 31, 2039

    granted

  2. US 10198218

    Injectable flowable composition comprising buprenorphine

    Indivior UK Limited · Granted Feb 5, 2019 · Expires Jan 31, 2039

    granted

  3. US 10196616

    Altered avian virus for in-ovo inoculation and methods of use thereof

    The United States of America, as represented by the Secretary of Agriculture · Granted Feb 5, 2019 · Expires Jan 31, 2039

    granted

  4. US 10196612

    Method of characterizing and manipulating adipose stem cell depots to a metabolically healthy state

    The United States of America as Represented by the Department of Veterens Affairs · Granted Feb 5, 2019 · Expires Jan 31, 2039

    granted

  5. US 10196458

    Anti-immunoglobulin E antibodies and methods of using thereof

    The Regents of the University of California · Granted Feb 5, 2019 · Expires Jan 31, 2039

    granted

  6. US 10196450

    Anti-OX40 antibodies and methods of using the same

    The Board of Regents of the University of Texas System · Granted Feb 5, 2019 · Expires Jan 31, 2039

    granted

  7. US 10195275

    Stable aqueous formulations of adalimumab

    Coherus BioSciences, Inc. · Granted Feb 5, 2019 · Expires Jan 31, 2039

    granted

  8. US 10196603

    Aligned and electrospun piezoelectric polymer fiber assembly and scaffold

    The United States of America as represented by the Administrator of NASA · Granted Feb 5, 2019 · Expires Jan 31, 2039

    granted

  9. US 10196596

    Engineered lumenized vascular networks and support matrix

    National Institutes of Health (NIH), U.S. Dept. of Health and Human Services (DHHS), The United States of America NIH Division of Extramural Inventions and Technology Resources (DEITR) · Granted Feb 5, 2019 · Expires Jan 31, 2039

    granted

  10. US 10196424

    Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases

    Protagonist Therapeutics, Inc. · Granted Feb 5, 2019 · Expires Jan 31, 2039

    granted

  11. US 10196393

    JAK inhibitors containing a 4-membered heterocyclic amide

    Theravance Biopharma R&D IP, LLC · Granted Feb 5, 2019 · Expires Jan 31, 2039

    granted

  12. US 10196403

    Compounds and compositions and uses thereof

    PGI Drug Discovery LLC · Granted Feb 5, 2019 · Expires Jan 31, 2039

    granted

  13. US 10196384

    Deuterated CFTR modulators

    Vertex Pharmaceuticals (Europe) Limited · Granted Feb 5, 2019 · Expires Jan 31, 2039

    granted

  14. US 10196383

    Substituted quinazoline compounds and preparation and uses thereof

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Feb 5, 2019 · Expires Jan 31, 2039

    granted

  15. US 10196372

    MYC G-quadruplex stabilizing small molecules and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 5, 2019 · Expires Jan 31, 2039

    granted

  16. US 10195297

    Iron garnet nanoparticles for cancer radiotherapy and chemotherapy

    The Board of Regents of the University of Texas System · Granted Feb 5, 2019 · Expires Jan 31, 2039

    granted

  17. US 10196378

    Inhibitors of BCR-ABL mutants and use thereof

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Feb 5, 2019 · Expires Jan 31, 2039

    granted

  18. US 10196443

    TEM8 antibodies and their use in treatment and detection of tumors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 5, 2019 · Expires Jan 31, 2039

    granted

  19. US 10196613

    Stem cells for modeling type 2 diabetes

    REGENERON PHARMACEUTICALS, INC. · Granted Feb 5, 2019 · Expires Jan 31, 2039

    granted

  20. US 10196425

    Peptide compositions

    RHYTHM PHARMACEUTICALS, INC. · Granted Feb 5, 2019 · Expires Jan 31, 2039

    granted

  21. US 10197577

    Serum antibody assay for determining protection from malaria, and pre-erythrocytic subunit vaccines

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 5, 2019 · Expires Jan 31, 2039

    granted

  22. US 10195151

    Formulations of (R)-2-amino-3-phenylpropyl carbamate

    Jazz Pharmaceuticals International III Limited · Granted Feb 5, 2019 · Expires Jan 31, 2039

    granted

  23. US 10196356

    Mixed disulfide conjugates of thienopyridine compounds and uses thereof

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Feb 5, 2019 · Expires Jan 31, 2039

    granted

  24. US 10195168

    Gamma-hydroxybutyrate compositions and their uses for the treatment of disorders

    Jazz Pharmaceuticals Ireland Limited · Granted Feb 5, 2019 · Expires Jan 31, 2039

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.